We found that both AGEs precursors, at nontoxic concentration, reduced the neuronal level of NSE with no effect on BDNF, PTRX-2, LCN-2, DJ-1, neurodegenerative markers and CML. This evidence concerns the gene PARK7 and chronic myelogenous leukemia, BCR-ABL1 positive.